Medication

If symptoms are severe or persistent, medication may be considered. This requires careful consideration and professional guidance.

Is medication safe?

Concerns about the safety of medication during pregnancy are understandable. Guidance is available on the website www.embryotox.de, run by the Charité University Hospital in Berlin, which evaluates medications specifically for pregnancy and breastfeeding. Older, well-researched preparations with which there is a lot of experience are often used deliberately – surprising risks are unlikely here.

If in doubt, talk to your gynecologist

A medical consultation is particularly important in order to realistically assess the benefits and possible risks. Your gynecologist can provide individual advice, suggest alternatives, and, if necessary, adjust or monitor your treatment.

Approved preparations

There are medications that are specifically approved for use during pregnancy or recommended for this situation. They are based on available study data and many years of practical experience.

“Off-label”

Some medications are also used outside their original approval. This so-called off-label use is legally permitted, but requires particularly careful medical consideration and information. Health insurance companies do not pay for such medications used "outside the approved indication."

Proven active ingredients

Some active ingredients have been used for many years and are considered proven. They are usually administered in low doses and under medical supervision to ensure the safest possible treatment.

Sources
  • Koren, Gideon, et al. "Effectiveness of delayed-release doxylamine and pyridoxine for nausea and vomiting of pregnancy: a randomized placebo controlled trial." American journal of obstetrics and gynecology 203.6 (2010): 571-e1.
  • Madjunkova, Svetlana, Caroline Maltepe, and Gideon Koren. "The delayed-release combination of doxylamine and pyridoxine (Diclegis®/Diclectin®) for the treatment of nausea and vomiting of pregnancy." Pediatric Drugs 16.3 (2014): 199-211.